This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MDCO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period BeOne Medicines Ltd. Announces Share Option GrantsJune 13 at 8:12 AM | tipranks.comGSK’s RSV Vaccine Expansion Under EMA ReviewJune 13 at 2:26 AM | tipranks.comEverest Medicines Expands Shareholder Base with Strategic Share DisposalJune 12 at 8:10 PM | tipranks.comBeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 | ONC Stock NewsJune 11 at 6:28 AM | gurufocus.comEverest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal AssociationJune 9, 2025 | investing.comEverest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for ...June 9, 2025 | gurufocus.comTYK Medicines, Inc. Seeks Approval for H Share Full CirculationJune 6, 2025 | tipranks.comBlueprint Medicines’ CSO Makes a Significant Stock Sale!June 5, 2025 | tipranks.com3D Medicines Inc. Announces Annual General Meeting to Discuss Key ResolutionsJune 5, 2025 | tipranks.com3D Medicines Inc. Announces Board Changes with New Non-Executive Director AppointmentJune 5, 2025 | tipranks.comStephens & Co. Downgrades Blueprint Medicines (BPMC) to Equal Weight, Cuts PTJune 5, 2025 | insidermonkey.comCitizens JMP Downgrades Blueprint Medicines (BPMC) to Market PerformJune 5, 2025 | insidermonkey.comBeOne Medicines: Competitive Advantage Of Zanubrutinib In The CLL FieldJune 4, 2025 | seekingalpha.comWolfe Research Lowered Blueprint Medicines Corporation (BPMC) from Outperform to Peer PerformJune 3, 2025 | insidermonkey.comBlueprint Medicines Corporation (BPMC) Downgraded at TD CowenJune 3, 2025 | insidermonkey.comEverest Medicines Announces Virtual AGM with Key ResolutionsJune 3, 2025 | tipranks.comWhy Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving PremarketJune 2, 2025 | benzinga.comBeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025June 2, 2025 | gurufocus.comBPMC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Blueprint Medicines ...June 2, 2025 | gurufocus.comBeOne Medicines Ltd (ONC) Unveils Promising Clinical Data at ASCO 2025 | ONC stock newsJune 2, 2025 | gurufocus.comBeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO ...June 2, 2025 | gurufocus.comBeOne Medicines (ONC) Reveals Promising Breast Cancer Treatment Data | ONC Stock NewsJune 2, 2025 | gurufocus.comBeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025June 2, 2025 | financialpost.comZealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndromeJune 2, 2025 | investing.comBeOne Medicines (ONC) Reveals Promising SEQUOIA Trial Results | ONC Stock NewsJune 1, 2025 | gurufocus.comBeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated ...May 31, 2025 | gurufocus.comBeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA's Differentiated ...May 31, 2025 | gurufocus.comBeOne Medicines Ltd (ONC) Unveils Promising Phase 3 SEQUOIA Trial Results for BRUKINSA | ONC ...May 31, 2025 | gurufocus.comBeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 2025May 31, 2025 | financialpost.comKingworld Medicines Group Ltd. AGM Resolutions Unanimously PassedMay 29, 2025 | tipranks.comBeOne Medicines Ltd. Forms Advisory Committee to Enhance Strategic OversightMay 28, 2025 | tipranks.comBeOne Medicines Ltd. Forms Scientific Advisory Committee to Boost R&D OversightMay 28, 2025 | tipranks.comBeOne Medicines Ltd. Strengthens Governance FrameworkMay 28, 2025 | tipranks.comBeOne Medicines Ltd. Forms Compensation Committee to Enhance GovernanceMay 28, 2025 | tipranks.comBeOne Medicines Ltd. Strengthens Financial Oversight with Audit Committee CharterMay 28, 2025 | tipranks.comBeOne Medicines Ltd. Announces Regulatory Filing UpdateMay 27, 2025 | tipranks.comBeOne Medicines Ltd. Announces Regulatory Filing with SECMay 27, 2025 | tipranks.comBeOne Medicines Ltd. Transitions to Swiss CorporationMay 27, 2025 | tipranks.comRevolution Medicines' SWOT analysis: stock shows promise amid clinical progressMay 26, 2025 | investing.comGSK’s Blenrep Receives Positive CHMP Opinion for Multiple Myeloma TreatmentMay 23, 2025 | tipranks.comSoleno Therapeutics' Marketing Authorization Application for Diazoxide Choline Tablets Validated by European Medicines Agency for Prader-Willi Syndrome TreatmentMay 22, 2025 | quiverquant.comBioArctic Gains EU Orphan Designation for MSA TreatmentMay 22, 2025 | tipranks.comFDA panel debates COVID vaccine recipe as questions swirl about fall shotsGovernment vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winterMay 22, 2025 | marketbeat.com4SC AG Faces Setback as EMA Signals Negative Opinion on ResminostatMay 20, 2025 | tipranks.comAlligator Bioscience Secures Pediatric Study Waiver for MitazalimabMay 20, 2025 | tipranks.comPraxis Precision Medicines to Participate in Upcoming ConferencesMay 20, 2025 | investing.comQuoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton SyndromeMay 20, 2025 | investing.comTYK Medicines Joins Hang Seng Biotech IndexMay 18, 2025 | tipranks.comRevolution Medicines (RVMD) Receives Adjusted Price Target from HC Wainwright | RVMD Stock NewsMay 14, 2025 | gurufocus.comRevolution Medicines (RVMD) Price Target Reduced by H.C. Wainwright Analyst | RVMD Stock NewsMay 14, 2025 | gurufocus.com Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.000.88▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼64▲MDCO Articles Average Week Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News Today CORT News Today JAZZ News Today PRGO News Today NKTR News Today SUPN News Today PCRX News Today OMER News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
